Universe Pharmaceuticals annual operating income
2019
2020
2021
2022
2023
2024
2025
Universe Pharmaceuticals Operating Income Growth & History (UPC)
Universe Pharmaceuticals's operating income was −$2.92B for fiscal 2025.
View full Universe Pharmaceuticals company overviewUniverse Pharmaceuticals annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | −$2.92B | $5.10B | — |
| 2024 | 2024-09-30 | −$8.02B | −$8.02B | — |
| 2023 | 2023-09-30 | −$4.0M | $3.1M | — |
| 2022 | 2022-09-30 | −$7.0M | −$20.6M | — |
| 2021 | 2021-09-30 | $13.6M | $3.3M | +32.56% |
| 2020 | 2020-09-30 | $10.3M | $498,896 | +5.12% |
| 2019 | 2019-09-30 | $9.8M | — | — |
Universe Pharmaceuticals operating income trends
Over the last five fiscal years, Universe Pharmaceuticals's operating income decreased from $10.3M to −$2.92B, a change of −$2.93B.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universe Pharmaceuticals source filings ↗